| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Judith Eschbach, Karin M Danze. α-Synuclein in Parkinson's disease: pathogenic function and translation into animal models. Neuro-degenerative diseases. vol 14. issue 1. 2015-02-12. PMID:24080741. |
parkinson's disease is a common neurodegenerative disease characterised by the loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of α-synuclein aggregates found in lewy bodies throughout the brain. |
2015-02-12 |
2023-08-12 |
mouse |
| Karl Grenier, Maria Kontogiannea, Edward A Fo. Short mitochondrial ARF triggers Parkin/PINK1-dependent mitophagy. The Journal of biological chemistry. vol 289. issue 43. 2015-02-12. PMID:25217637. |
parkinson disease (pd) is a complex neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. |
2015-02-12 |
2023-08-13 |
Not clear |
| Vannary Tieng, Luc Stoppini, Sabrina Villy, Marc Fathi, Michel Dubois-Dauphin, Karl-Heinz Kraus. Engineering of midbrain organoids containing long-lived dopaminergic neurons. Stem cells and development. vol 23. issue 13. 2015-02-05. PMID:24576173. |
the possibility to generate dopaminergic (da) neurons from pluripotent stem cells represents an unlimited source of material for tissue engineering and cell therapy for neurodegenerative disease. |
2015-02-05 |
2023-08-12 |
Not clear |
| Chien-Wei Feng, Zhi-Hong Wen, Shi-Ying Huang, Han-Chun Hung, Chun-Hong Chen, San-Nan Yang, Nan-Fu Chen, Hui-Min Wang, Chung-Der Hsiao, Wu-Fu Che. Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae. Zebrafish. vol 11. issue 3. 2015-02-04. PMID:24720843. |
parkinson's disease (pd) is a neurodegenerative disease that is characterized by the progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2015-02-04 |
2023-08-13 |
zebrafish |
| Natasa Kustrimovic, Emanuela Rasini, Massimiliano Legnaro, Franca Marino, Marco Cosentin. Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 9. issue 3. 2015-01-26. PMID:24682738. |
expression of dopaminergic receptors on human cd4+ t lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. |
2015-01-26 |
2023-08-12 |
human |
| Jesse V Veenvliet, Marten P Smid. Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives. Cellular and molecular life sciences : CMLS. vol 71. issue 24. 2015-01-26. PMID:25064061. |
dopaminergic (da) neurons in the ventral mesodiencephalon control locomotion and emotion and are affected in psychiatric and neurodegenerative diseases, such as parkinson's disease (pd). |
2015-01-26 |
2023-08-13 |
Not clear |
| Min Zhu, Wen-Wei Li, Chuan-Zhen L. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. CNS neuroscience & therapeutics. vol 20. issue 4. 2014-12-09. PMID:24351065. |
parkinson's disease (pd) is a common neurodegenerative disease, characterized by progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2014-12-09 |
2023-08-12 |
Not clear |
| Xiaoying Wang, Guiyun Cui, Xinxin Yang, Zunsheng Zhang, Hongjuan Shi, Jie Zu, Fang Hua, Xia She. Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease. Brain research bulletin. vol 103. 2014-12-03. PMID:24583079. |
parkinson's disease (pd) is a neurodegenerative disease characterized by loss of dopaminergic neurons in the substantia nigra. |
2014-12-03 |
2023-08-12 |
rat |
| Xiu-Qi Bao, Xiang-Chen Kong, Li-Bing Kong, Liang-Yu Wu, Hua Sun, Dan Zhan. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models. Brain research. vol 1547. 2014-09-15. PMID:24384139. |
parkinson's disease (pd) is a neurodegenerative disease affecting up to 80% of dopaminergic neurons in the nigrostriatal pathway. |
2014-09-15 |
2023-08-12 |
rat |
| Eun Hee Ahn, Dae Won Kim, Min Jea Shin, Young Nam Kim, Hye Ri Kim, Su Jung Woo, So Mi Kim, Duk-Soo Kim, Joon Kim, Jinseu Park, Won Sik Eum, Hyun Sook Hwang, Soo Young Cho. PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model. Free radical biology & medicine. vol 55. 2014-08-20. PMID:23178948. |
parkinson's disease (pd) is a neurodegenerative disease characterized by a gradual loss of dopaminergic (da) neurons in the substantia nigra (sn) of the brain. |
2014-08-20 |
2023-08-12 |
mouse |
| Theresa A Zesiewicz, Pablo Martinez-Marti. Effects of rotigotine transdermal system on non-motor symptoms in Parkinson's disease: an overview. Expert review of neurotherapeutics. vol 13. issue 12. 2014-08-06. PMID:24236902. |
parkinson's disease (pd) is a progressive neurodegenerative disease, involving the dopaminergic, noradrenergic, serotonergic and cholinergic systems. |
2014-08-06 |
2023-08-12 |
Not clear |
| Saeed Esmaeili-Mahani, Somayeh Vazifekhah, Hamzeh Pasban-Aliabadi, Mehdi Abbasnejad, Vahid Sheiban. Protective effect of orexin-A on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells. Neurochemistry international. vol 63. issue 8. 2014-07-22. PMID:24135219. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by progressive and selective death of midbrain dopaminergic neurons. |
2014-07-22 |
2023-08-12 |
human |
| Sabrina M Heman-Ackah, Martina Hallegger, Mahendra S Rao, Matthew J A Woo. RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis. Frontiers in molecular neuroscience. vol 6. 2014-06-24. PMID:24312000. |
parkinson's disease (pd) is a debilitating neurodegenerative disease characterized primarily by the selective death of dopaminergic (da) neurons in the substantia nigra pars compacta of the midbrain. |
2014-06-24 |
2023-08-12 |
Not clear |
| Genaro Gabriel Ortiz, Fermín P Pacheco-Moisés, Víctor M Gómez-Rodríguez, Erika D González-Renovato, Erandhis D Torres-Sánchez, Ana C Ramírez-Anguian. Fish oil, melatonin and vitamin E attenuates midbrain cyclooxygenase-2 activity and oxidative stress after the administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Metabolic brain disease. vol 28. issue 4. 2014-06-20. PMID:23703110. |
parkinson's disease is a neurodegenerative disease whose hallmark pathological features include a selective loss of dopaminergic neurons in the midbrain. |
2014-06-20 |
2023-08-12 |
mouse |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons. Molecular and cellular neurosciences. vol 56. 2014-06-20. PMID:23831389. |
parkinson's disease is the second most common neurodegenerative disease, and is characterised by the progressive degeneration of the nigrostriatal dopaminergic (da) system. |
2014-06-20 |
2023-08-12 |
human |
| Xian-Ming Luo, Hai Lin, Wei Wang, Marilyn S Geaney, Lee Law, Shaun Wynyard, Shamim B Shaikh, Henry Waldvogel, Richard L M Faull, Robert B Elliott, Stephen J M Skinner, Jacqueline E Lee, Paul L-J Ta. Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells. Journal of Parkinson's disease. vol 3. issue 3. 2014-06-17. PMID:24002224. |
parkinson's disease (pd) is a neurodegenerative disease that is primarily characterized by degeneration of dopaminergic (da) neurons in the substantia nigra (sn) and a loss of their fibre projections in the striatum. |
2014-06-17 |
2023-08-12 |
monkey |
| Jesús Pérez-H, Carlos Carrillo-S, Esperanza García, Gabriela Ruiz-Mar, Ruy Pérez-Tamayo, Anahí Chavarrí. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Toxicology. vol 319. 2014-06-10. PMID:24607817. |
parkinson's disease (pd) is a neurodegenerative disease secondary to the loss of dopaminergic neurons in the substantia nigra. |
2014-06-10 |
2023-08-12 |
mouse |
| Li Li, Huizhen Chen, Fangfang Chen, Feng Li, Meng Wang, Li Wang, Yunqing Li, Dianshuai Ga. Effects of glial cell line-derived neurotrophic factor on microRNA expression in a 6-hydroxydopamine-injured dopaminergic cell line. Journal of neural transmission (Vienna, Austria : 1996). vol 120. issue 11. 2014-06-09. PMID:23771700. |
parkinson's disease (pd) is the second most prevalent, progressive neurodegenerative disease and is characterized by the irreversible and selective loss of nigrostriatal dopaminergic (da) neurons. |
2014-06-09 |
2023-08-12 |
Not clear |
| Chu Lan Lao, Yen-Hsi Kuo, Yueh-Ting Hsieh, Jin-Chung Che. Intranasal and subcutaneous administration of dopamine D3 receptor agonists functionally restores nigrostriatal dopamine in MPTP-treated mice. Neurotoxicity research. vol 24. issue 4. 2014-04-29. PMID:23820985. |
parkinson's disease (pd) is a neurodegenerative disease with a hallmark motor defect caused by the death of dopaminergic neurons in the substantia nigra. |
2014-04-29 |
2023-08-12 |
mouse |
| Kai Gao, Xiong Deng, Wen Zheng, Zhi Song, Anding Zhu, Xiaofei Xiu, Hao Den. Genetic analysis of the FBXO42 gene in Chinese Han patients with Parkinson's disease. BMC neurology. vol 13. 2014-04-04. PMID:24063688. |
parkinson's disease (pd), the second most common neurodegenerative disease, is characterized by loss of dopaminergic neurons in the substantia nigra. |
2014-04-04 |
2023-08-12 |
Not clear |